Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The non-label dialysis regimens are separate GlobalRPh reference material, not manufacturer instructions. No renal-adjusted meningitis regimen is inferred.
Check source scope before reading a dose
Nebraska Medicine - meropenem by CVVHD flow
Product / population
Adults; IV meropenem, source PDF page 7.
Renal method
CVVHD dialysate flow, with indication/MIC stratification.
Source revision
2023 CRRT/PIRRT reference.
Retrieved
2026-09-05
Local review status
Locally included source-specific summary. Regimen differences are not automatically resolved.
University of Nebraska Medical Center / Nebraska Medicine · Adults; IV meropenem, source PDF page 7.
Renal method: CVVHD dialysate flow, with indication/MIC stratification. Source date: 2023 CRRT/PIRRT reference. Retrieved: 2026-09-05
Locally included source-specific summary. Regimen differences are not automatically resolved.
Dosing / renal protocol and limits
Standard CVVHD treatment: 1 g IV load then 500 mg every 6 hours at dialysate flow 1-4 L/hour. For meningitis, cystic fibrosis or MIC 4, the guide uses 2 g loading, then 2 g every 12 hours at 1 L/hour or every 8 hours at 2-4 L/hour. Do not use the anephric non-CRRT column while clearance is being provided by CVVHD.
RDM30-063-meropenem-1 · Source locator: Nebraska Medicine - meropenem by CVVHD flow; renal/dosing sections and stated qualifiers
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.